Type 1 diabetes

Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study

Diabetes MetabPublished Cross-sectional study

Authors' conclusion

TAR1 was independently associated with increased CAP values, even after adjustment for age, BMI, sex, HbA1c, and total daily insulin dose, suggesting a potential role for glycemic variability in hepatic fat accumulation in adults with T1D.

Study context

Population
Adults with established T1D undergoing vibration-controlled transient elastography (VCTE) with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP), all with continuous glucose monitoring (CGM); mean age 54±13 years, mean body mass index (BMI) 25.8 ± 5.6 kg/m², mean HbA1c 7.7 ± 1.4 %
Participants
262 adults
Outcome
Association between CGM-derived glycemic metrics and MASLD (CAP ≥248 dB/m plus ≥1 cardiometabolic risk factor) / CAP values
Methodological detailsmulticenter, consecutive enrolment
  • Multicenter
  • Consecutive enrolment

Main finding

As reported in the abstract

Association of TAR1 (time above range 180-250 mg/dl) with CAP

TAR1 associated with increased CAP values

quantile regression coefficient 1.037 (95% CI [0.216;1.858])

P = 0.013

Observational data: associations, not effects.

Further findings

Prevalence of MASLD

MASLD prevalence (n = 92)
35.1 %

Prevalence of significant liver fibrosis (LSM ≥8 kPa)

Significant liver fibrosis prevalence (n = 12)
4.6 %

Variable importance for CAP (random forest regression)

BMI most important factor, followed by age, total daily insulin dose and TAR1

Original publication

Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study. Diabetes Metab. Published 5 July 2025. doi:10.1016/j.diabet.2025.101684

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.